FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome
Sign Up to like & getrecommendations! Published in 2020 at "Blood Cancer Journal"
DOI: 10.1038/s41408-020-00362-7
Abstract: Myelodysplastic syndrome (MDS) is a heterogeneous myeloid malignancy characterized by blood cell morphological dysplasia, ineffective clonal hematopoiesis, and risk of transformation to secondary acute myeloid leukemia (sAML). A number of genetic abnormalities have been identified… read more here.
Keywords: tumor suppressor; myelodysplastic syndrome; fbxo11; transformation ... See more keywords
FBXO11 governs macrophage cell death and inflammation in response to bacterial toxins
Sign Up to like & getrecommendations! Published in 2023 at "Life Science Alliance"
DOI: 10.26508/lsa.202201735
Abstract: FBXO11 regulates the expression of the complement receptor C5aR1 and the inflammatory cytokine IL-1β, affecting how macrophages respond to Staphylococcus aureus pore–forming toxins. Staphylococcus aureus causes severe infections such as pneumonia and sepsis depending on… read more here.
Keywords: c5ar1; inflammation; fbxo11; expression ... See more keywords